ArticleContemporary clinical trials communications2026
Type I error control and interim monitoring for co-primary hypotheses involving a subgroup in the Outpatient Treatment with Anti-Coronavirus Immunoglobulin (OTAC) trial.
Jiayi Hu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.